ClinicalTrials.gg
Sign In

Neuroinflammatory Diseases clinical trials

The registry lists 180 studies for Neuroinflammatory Diseases across more than 10 countries. 80 are recruiting or about to start. 24 of them are mainly about Neuroinflammatory Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Neuroinflammatory Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
66
Recruiting
53
Not yet recruiting
22
Status unknown
12
Active, not recruiting
10
Terminated
9

Phase

Phase 2
32
Phase 1
18
Phase 4
10
Phase 3
4
Early Phase 1
2

Where

United States
59
Italy
19
France
12
Turkey
9
Netherlands
7
China
6

Who runs them

National Institute of Mental Health (NIMH) (9) · Assistance Publique - Hôpitaux de Paris (5) · Leiden University Medical Center (3) · Karolinska University Hospital (2) · Centre Hospitalier St Anne (2) · Ain Shams University (2) · Penn State University (2) · Bayer (2)

What is being tested here

Drugs under test in Neuroinflammatory Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexmedetomidine203
Minocycline113
Immunoglobulins, Intravenous102
Immunoglobulin G102
Orelabrutinib101
Norethindrone Acetate101
Norethindrone101
Elagolix101
Ascorbic Acid101
Palmidrol101

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 2 open · NSAIDs 4

Coming up

1phase 3 study under way
25studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 53 Neuroinflammatory Diseases studies recruiting now, 16 (30%) set no upper age limit and 24 (45%) stop at 75 or younger. 11 (21%) take children under 18. 1 (2%) are for women only and 2 (4%) for men only; 17 (32%) take healthy volunteers.

Recruiting studies that take each age, of 53
AgeWomenMen
1011 (21%)11 (21%)
1830 (57%)32 (60%)
3030 (57%)32 (60%)
4033 (62%)33 (62%)
5039 (74%)39 (74%)
6542 (79%)42 (79%)
7532 (60%)32 (60%)
8523 (43%)23 (43%)

Across all 180 studies, recruiting or not: 44% stop at 75 or younger and 30% at 65; 13% take children; 4% are for women only and 5% for men only; 38% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Neuroinflammatory Diseases studies take

Of 34 interventional studies with no phase under Neuroinflammatory Diseases, half reached primary completion within 27 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase27 mo23–44 · 34 studies——
Observational51 mo13–84 · 34 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 180. Browse all 180 → or search them.